No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CN Stock MarketDetailed Quotes
002007 Hualan Biological Engineering, Inc.
- 16.21
- -0.64-3.80%
Not Open Jan 2 15:00 CST
29.64BMarket Cap22.14P/E (TTM)
16.95High16.13Low148.74KlotVolume16.81Open16.85Pre Close244.97MTurnover0.95%Turnover Ratio20.01P/E (Static)1.83BShares21.1552wk High2.53P/B25.51BFloat Cap13.7252wk Low18.54Limit Up1.57BShs Float74.90Historical High15.17Limit Down4.87%Amplitude-2.28Historical Low0.30Dividend TTM16.47Avg Price88.89KlotAsk1.85%Div YieldTTM100Lot Size55.69KlotBid
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Hualan Biological Engineering, Inc.: The Chongqing subsidiary has obtained a blood plasma collection license.
Hualan biological engineering, inc. (002007.SZ): The application for registration of rituximab injection has been accepted.
Hualan Biological Engineering, Inc. (002007.SZ) announced that its affiliated company Hualan Genetic Engineering Co., Ltd. has received notification from the national pharmaceutical regulatory authority...
Hualan Biological Engineering's Unit Gets Certificate for Cancer Drug's Registration
Express News | Hualan biological engineering, inc.: The gene company has obtained the registration certificate for the pharmaceutical Bevacizumab Injection.
Hualan Biological Engineering, Inc.: Third quarter report of 2024.
hualan biological engineering, inc. (002007.SZ) released its performance for the first three quarters, with a net income of 0.924 billion yuan, a year-on-year decrease of 13.46%.
hualan biological engineering, inc. (002007.SZ) released the third quarter report for 2024, achieving revenue in the first three quarters...
Top CN Stock Gainers
See the daily top gainer.
